Imagine standing here before the Bayer AG Pharmaceuticals Division. This location is more than just a building. It is a portal into a world of scientific innovation and a story of significant historical events.
Bayer AG Pharmaceuticals Division stands as a testament to Berlin’s central role in pharmaceutical advancement. It also highlights Germany’s broader contribution to global healthcare.
Bayer was founded in 1863. It began as a dyestuffs factory. Friedrich Bayer and Johann Friedrich Weskott started the company. Their goal was to produce synthetic dyes. This was a groundbreaking idea for the textile industry. Natural dyes were expensive and hard to get.
The company quickly grew. In 1881 it transformed into a joint stock company. It was then called Farbenfabriken vorm. Friedr. Bayer & Co. The number of employees increased significantly. It went from three in 1863 to over 300 by 1881.
Bayer expanded its business beyond dyes. Carl Duisberg established a major research program. This was crucial for Bayer’s future. The company built a scientific laboratory in Wuppertal-Elberfeld. This became Bayer’s headquarters from 1878 to 1912. These steps led to new products. Heroin was created in 1895. It was sold over-the-counter for pain relief. Aspirin followed in 1899. Felix Hoffman developed it. Aspirin became known as the “drug of the century”.
Bayer created foreign affiliated companies. They wanted to expand internationally. They secured positions in markets like the UK, the US, Russia, Belgium, and France. By 1913, 1,000 of Bayer’s 10,000 employees worked outside Germany.
World War I had a devastating effect. Bayer produced war materials. These included explosives and chemical weapons. The company was cut off from export markets. Sales of dyes and pharmaceuticals dropped. Bayer lost most of its foreign assets. Its US assets were confiscated in 1917.
In 1925, Bayer merged with other companies. This created I.G. Farbenindustrie AG. Bayer transferred its assets. The Bayer tradition continued. The Bayer Cross was used for all of I.G.’s pharmaceutical products.
Gerhard Domagk discovered the therapeutic effect of sulfonamides in the early 1930s. He worked with Fritz Mietzsch and Joseph Klarer. Prontosil was the first commercially available antibacterial antibiotic. Domagk received the Nobel Prize in 1939 for this discovery.
World War II brought more challenges. The Leverkusen site was considered vital to the war. Foreign and forced laborers were brought in. They came from occupied countries in Europe.
American troops arrived in Leverkusen on April 14, 1945. The British military government took control. The Allied Forces confiscated I.G. in November 1945. The company was to be dissolved.
Ulrich Haberland rebuilt the company. Farbenfabriken Bayer AG was newly established on December 19, 1951.
Bayer AG successfully entered the women’s contraception market. In 1960, the first “Pill” was approved in the USA. Bayer’s Anovlar was approved in Europe a year later.
Bayer refocused on international activities. They acquired Cutter Laboratories Inc. in 1974. They also acquired Miles Laboratories Inc. in 1978. They intensified research and development. The cardiovascular drug Adalat and the antibiotic Ciprobay/Cipro were created.
In 1994, Bayer regained the rights to its name in the United States. This allowed them to operate under their own name and logo.
In 2006, Bayer acquired Schering AG. It was officially renamed Bayer Schering Pharma. In 2011, it became Bayer HealthCare Pharmaceuticals.
Today, Bayer HealthCare concentrates on cardiovascular diseases, oncology, ophthalmology, women’s healthcare, and imaging techniques. The Bayer AG Pharmaceuticals Division here in Berlin stands as a reminder of a long and complex history. It shows the evolution of pharmaceuticals and their impact on global health.